Fig. 3From: Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulationsStructures of synperiplanar A and antiperiplanar B conformersBack to article page
